Keywords: sucampo, takeda, sign, ibs, drug, deal, pharmaceuticals

Sucampo and Takeda sign IBS drug deal

Article | 08 November 2004

Print This

Sucampo Pharmaceuticals of the USA and Japan's Takeda have entered into a collaboration and license agreement for the former's lubiprostone. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in